Open AccessRetrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas
Author(s) -
Vincent A Van Vugt,
David Piccioni,
Bradley Brown,
Tiffany A. Brown,
Marlon Garzo Saria,
Tiffany Juarez,
Santosh Kesari
Publication year - 2014
Publication title -
cns oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 20
eISSN - 2045-0915
pISSN - 2045-0907
DOI - 10.2217/cns.14.29
Subject(s) - temozolomide , medicine , dosing , regimen , retrospective cohort study , oncology , surgery , chemotherapy
We report the safety and feasibility of a 3 days on/11 days off temozolomide regimen for the treatment of recurrent malignant gliomas.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom